Answer
Following a single oral 150 mg dose of ripretinib in humans, mean elimination half-lives were 12.6 hours (CV 17%) for ripretinib and 15.6 hours (CV 23%) for its active metabolite DP-5439.
Sources for this answer
- QINLOCK 50 mg tabletsDeciphera · emc · SmPC §5.2 Pharmacokinetic properties · Version 2Document updated
Sources checked